Brain volumes and risk of cardiovascular events and mortality. The SMART-MR study

Neurobiology of Aging

Volumn 35, Issue 7, 2014, Pages 1624-1631

  van der Veen, Pieternella H ^a   Muller, Majon ^a,b   Vincken, Koen L ^c   Mali, Willem P T M ^a   van der Graaf, Yolanda ^a   Geerlings, Mirjam I ^a   Algra, A ^a   Doevendans, P A ^d   Van der Graaf, Y ^e   Grobbee, D E ^e   Rutten, G E H M ^e   Kappelle, L J ^f   Mali, W P Th M ^d   Moll, F L ^d   Visseren, F L J ^d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d Department of Cardiology ^*  (United States)

^e Julius Center for Health Sciences and Primary Care   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Atherosclerosis; Brain imaging; Cardiovascular events; Cohort; Epidemiology; Mortality

Indexed keywords

ADULT; AGED; ARTERY DISEASE; ARTICLE; BRAIN ISCHEMIA; BRAIN SIZE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROSPINAL FLUID; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; GRAY MATTER; HEART EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; WHITE MATTER; WHITE MATTER LESION;

ATHEROSCLEROSIS; BRAIN IMAGING; CARDIOVASCULAR EVENTS; COHORT; EPIDEMIOLOGY; MORTALITY;

ATROPHY; BRAIN; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; ORGAN SIZE; PROGNOSIS; RISK; RISK FACTORS; STROKE; TIME FACTORS;

EID: 84903366977     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.02.003     Document Type: Article

References (34)

1. Achterberg S., Cramer M.J., Kappelle L.J., de Borst G.J., Visseren F.L., van der Graaf Y., Algra A. Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study. Eur. J. Cardiovasc. Prev. Rehabil. 2010, 17:424-430.
2. Altmann-Schneider I., Trompet S., de Craen A.J., van Es A.C., Jukema J.W., Stott D.J., Sattar N., Westendorp R.G., van Buchem M.A., van der Grond J. Cerebral microbleeds are predictive of mortality in the elderly. Stroke 2011, 42:638-644.
3. Anbeek P., Vincken K.L., van Bochove G.S., van Osch M.J., van der Grond J. Probabilistic segmentation of brain tissue in MR imaging. Neuroimage 2005, 27:795-804.
4. Bokura H., Kobayashi S., Yamaguchi S., Iijima K., Nagai A., Toyoda G., Oguro H., Takahashi K. Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: a prospective cohort study. J.Stroke Cerebrovasc. Dis. 2006, 15:57-63.
5. Briley D.P., Haroon S., Sergent S.M., Thomas S. Does leukoaraiosis predict morbidity and mortality?. Neurology 2000, 54:90-94.
6. Brundel M., de Bresser J., van Dillen J.J., Kappelle L.J., Biessels G.J. Cerebral microinfarcts: a systematic review of neuropathological studies. J.Cereb. Blood Flow Metab. 2012, 32:425-436.
7. Conijn M.M., Kloppenborg R.P., Algra A., Mali W.P., Kappelle L.J., Vincken K.L., van der Graaf Y., Geerlings M.I. Cerebral small vessel disease and risk of death, ischemic stroke, and cardiac complications in patients with atherosclerotic disease: the Second Manifestations of ARTerial disease-Magnetic Resonance (SMART-MR) study. Stroke 2011, 42:3105-3109.
8. de Bresser J., Tiehuis A.M., van den Berg E., Reijmer Y.D., Jongen C., Kappelle L.J., Mali W.P., Viergever M.A., Biessels G.J. Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care 2010, 33:1309-1314.
9. Debette S., Beiser A., DeCarli C., Au R., Himali J.J., Kelly-Hayes M., Romero J.R., Kase C.S., Wolf P.A., Seshadri S. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke 2010, 41:600-606.
10. Fotenos A.F., Snyder A.Z., Girton L.E., Morris J.C., Buckner R.L. Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD. Neurology 2005, 64:1032-1039.
11. Geerlings M.I., Appelman A.P., Vincken K.L., Algra A., Witkamp T.D., Mali W.P., van der Graaf Y. Brain volumes and cerebrovascular lesions on MRI in patients with atherosclerotic disease. The SMART-MR study. Atherosclerosis 2010, 210:130-136.
12. Gerdes V.E., Kwa V.I., ten Cate H., Brandjes D.P., Buller H.R., Stam J. Cerebral white matter lesions predict both ischemic strokes and myocardial infarctions in patients with established atherosclerotic disease. Atherosclerosis 2006, 186:166-172.
13. Hassan A., Hunt B.J., O'Sullivan M., Parmar K., Bamford J.M., Briley D., Brown M.M., Thomas D.J., Markus H.S. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003, 126:424-432.
14. Henneman W.J., Sluimer J.D., Cordonnier C., Baak M.M., Scheltens P., Barkhof F., van der Flier W.M. MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population. Stroke 2009, 40:492-498.
15. Ikram M.A., Vernooij M.W., Vrooman H.A., Hofman A., Breteler M.M. Brain tissue volumes and small vessel disease in relation to the risk of mortality. Neurobiol. Aging 2009, 30:450-456.
16. Ikram M.A., Vrooman H.A., Vernooij M.W., van der Lijn F., Hofman A., van der Lugt A., Niessen W.J., Breteler M.M. Brain tissue volumes in the general elderly population. The Rotterdam Scan Study. Neurobiol. Aging 2008, 29:882-890.
17. Jokinen H., Lipsanen J., Schmidt R., Fazekas F., Gouw A.A., van der Flier W.M., Barkhof F., Madureira S., Verdelho A., Ferro J.M., Wallin A., Pantoni L., Inzitari D., Erkinjuntti T. Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study. Neurology 2012, 78:1785-1792.
18. Kerber K.A., Whitman G.T., Brown D.L., Baloh R.W. Increased risk of death in community-dwelling older people with white matter hyperintensities on MRI. J.Neurol. Sci. 2006, 250:33-38.
19. Kloppenborg R.P., Nederkoorn P.J., Grool A.M., Vincken K.L., Mali W.P., Vermeulen M., van der Graaf Y., Geerlings M.I. Cerebral small-vessel disease and progression of brain atrophy: the SMART-MR study. Neurology 2012, 79:2029-2036.
20. Knopman D.S., Penman A.D., Catellier D.J., Coker L.H., Shibata D.K., Sharrett A.R., Mosley T.H. Vascular risk factors and longitudinal changes on brain MRI: the ARIC study. Neurology 2011, 76:1879-1885.
21. Kooistra M., Geerlings M.I., van der Graaf Y., Mali W.P., Vincken K.L., Kappelle L.J., Muller M., Biessels G.J. Vascular brain lesions, brain atrophy, and cognitive decline. The Second Manifestations of ARTerial disease-Magnetic Resonance (SMART-MR) study. Neurobiol. Aging 2014, 35:35-41.
22. Kuller L.H., Arnold A.M., Longstreth W.T., Manolio T.A., O'Leary D.H., Burke G.L., Fried L.P., Newman A.B. White matter grade and ventricular volume on brain MRI as markers of longevity in the cardiovascular health study. Neurobiol. Aging 2007, 28:1307-1315.
23. Launer L.J., Hughes T.M., White L.R. Microinfarcts, brain atrophy, and cognitive function: the Honolulu Asia aging study autopsy study. Ann. Neurol. 2011, 70:774-780.
24. Longstreth W.T., Arnold A.M., Kuller L.H., Bernick C., Lefkowitz D.S., Beauchamp N.J., Manolio T.A. Progression of magnetic resonance imaging-defined brain vascular disease predicts vascular events in elderly: the Cardiovascular Health Study. Stroke 2011, 42:2970-2972.
25. McKinley M.J., Gerstberger R., Mathai M.L., Oldfield B.J., Schmid H. The lamina terminalis and its role in fluid and electrolyte homeostasis. J.Clin. Neurosci. 1999, 6:289-301.
26. Muller M., van der Graaf Y., Visseren F.L., Vlek A.L., Mali W.P., Geerlings M.I. Blood pressure, cerebral blood flow, and brain volumes. The SMART-MR study. J.Hypertens. 2010, 28:1498-1505.
27. Olesen P.J., Guo X., Gustafson D., Borjesson-Hanson A., Sacuiu S., Eckerstrom C., Bigler E.D., Skoog I. Apopulation-based study on the influence of brain atrophy on 20-year survival after age 85. Neurology 2011, 76:879-886.
28. Rosano C., Aizenstein H., Brach J., Longenberger A., Studenski S., Newman A.B. Special article: gait measures indicate underlying focal gray matter atrophy in the brain of older adults. J.Gerontol. A Biol. Sci. Med. Sci. 2008, 63:1380-1388.
29. Sachs G.A., Carter R., Holtz L.R., Smith F., Stump T.E., Tu W., Callahan C.M. Cognitive impairment: an independent predictor of excess mortality: a cohort study. Ann. Intern. Med. 2011, 155:300-308.
30. Simons P.C., Algra A., van de Laak M.F., Grobbee D.E., van der Graaf Y. Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur. J. Epidemiol. 1999, 15:773-781.
31. Staff R.T., Murray A.D., Ahearn T., Salarirad S., Mowat D., Starr J.M., Deary I.J., Lemmon H., Whalley L.J. Brain volume and survival from age 78 to 85: the contribution of Alzheimer-type magnetic resonance imaging findings. J.Am. Geriatr. Soc. 2010, 58:688-695.
32. Tabarean I., Morrison B., Marcondes M.C., Bartfai T., Conti B. Hypothalamic and dietary control of temperature-mediated longevity. Ageing Res. Rev. 2010, 9:41-50.
33. Wardlaw J.M., Sandercock P.A., Dennis M.S., Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?. Stroke 2003, 34:806-812.
34. Xie J., Brayne C., Matthews F.E. Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up. BMJ 2008, 336:258-262.